BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 14966259)

  • 1. Factors that influence prescribing decisions.
    Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
    Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that influence prescribing within a therapeutic drug class.
    Nutescu EA; Park HY; Walton SM; Blackburn JC; Finley JM; Lewis RK; Schumock GT
    J Eval Clin Pract; 2005 Aug; 11(4):357-65. PubMed ID: 16011648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The perceived influence of clinical pharmacy services on physician prescribing behavior: a matched-pair comparison of pharmacists and physicians.
    Sulick JA; Pathak DS
    Pharmacotherapy; 1996; 16(6):1133-41. PubMed ID: 8947987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical services provided by staff pharmacists in a community hospital.
    Garrelts JC; Smith DF
    Am J Hosp Pharm; 1990 Sep; 47(9):2011-5. PubMed ID: 2244945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary-control procedures in a staff-model health maintenance organization.
    Lyon RA
    Am J Hosp Pharm; 1990 Feb; 47(2):340-2. PubMed ID: 2106782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles.
    Niquille A; Ruggli M; Buchmann M; Jordan D; Bugnon O
    Ann Pharmacother; 2010 Apr; 44(4):650-7. PubMed ID: 20215496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing.
    Stewart DC; George J; Diack HL; Bond CM; McCaig DJ; Cunningham IS; Munro K; Pfleger D
    Ann Pharmacother; 2009 Jun; 43(6):1115-21. PubMed ID: 19417108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.
    Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J
    Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delisting of drugs in Ontario. How attitudes and prescribing strategies of family physicians in the Kingston area changed.
    Godwin M; Chapman J; Mowat D; Racz W; McBride J; Tang J
    Can Fam Physician; 1996 Jul; 42():1309-16. PubMed ID: 8754700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans.
    Ganther-Urmie JM; Nair KV; Valuck R; McCollum M; Lewis SJ; Turpin RS
    Am J Manag Care; 2004 Mar; 10(3):201-8. PubMed ID: 15032257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of adherence to drug recommendations by providing feedback of outpatient prescribing patterns to hospital specialists.
    Wettermark B; Haglund K; Gustafsson LL; Persson PM; Bergman U
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):579-88. PubMed ID: 15818639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intervention to develop repeat prescribing in community pharmacy.
    Saastamoinen LK; Klaukka TJ; Ilomäki J; Enlund H
    J Clin Pharm Ther; 2009 Jun; 34(3):261-5. PubMed ID: 19646075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physicians' expectations towards pharmacy services on ward].
    Bourget S; Allenet B; Bedouch P; Bosson LJ; Calop J
    J Pharm Belg; 2007; 62(4):130-4. PubMed ID: 18269141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.